MnTBAP treatment reduces caloric intake in mice fed a HFD. by Jonathan R. Brestoff (799142)

The HO-1 inhibitor SnMP does not block MnTBAP’s ability to reduce body weight, adipose tissue mass, and caloric intake in mice fed HFD. by Jonathan R. Brestoff (799142)

Changes in the gut microbiota and metabolites after <i>T</i>. <i>spiralis</i> infection. by Chengyao Li (311264)

Surface Immobilization of Human Arginase-1 with an Engineered Ice Nucleation Protein Display System in <i>E</i>. <i>coli</i> by Zhen Zhang (86004)

“…<div><p>Ice nucleation protein (INP) is frequently used as a surface anchor for protein display in gram-negative bacteria. …”

Localization in a circular map of <i>scpB</i>, <i>lmb</i>, <i>fbsA</i>, <i>fbsB</i>, <i>acp</i>, <i>hvgA</i>, Pili (PI-1, PI-2a and PI-2b), and <i>cylE</i> identified in 14 GBS iso... by Gerardo del Carmen Palacios-Saucedo (12250969)

Long function evolution of the montelukast and placebo group. by David Ruttens (5071316)

Schematic approach to define the threshold window for segmentation of ‘lesion area’ and the ventricular space. by Hadijat M. Makinde (5791190)

Percent cover of <i>S</i>. <i>pacifica</i> (top row) and subordinate species (bottom row) at high, medium and low elevations (left to right). by Akana E. Noto (3623366)

The state of the MD system in response to stress for varying connectivity. by Angélique O. J. Cramer (339170)

Intrathecal (i.t.) pre- or posttreatment with EphB1-Fc inhibited chronic constrictive injury (CCI)-induced neuropathic pain and spinal Fos protein expression, accompanied by the de... by Li-Na Yu (312492)

“…(B) The representative immunohistochemical staining and the quantitative data for the decreased CCI-induced spinal Fos expression by pretreatment with EphB1-Fc. ** <i>P</i><0.01 compared with saline (Sal)-CCI group, n = 6 mice in each group, Scale bar = 100 µm. …”

Effect sizes on the Poisson multivariate regression with and without propensity score matching in healthcare workers, doctors/physicians, and nurses. by Javier A. Flores-Cohaila (16933983)

Decisions of managers by tier. by Joseph D. O’Brien (10224377)

“…<p>(a) Distributions of the total net points earned by managers in the gameweek following a transfer, i.e., the points scored by the player brought in minus that of the player transferred out. …”

LOH at <i>KSR1</i> affects cellular lipid profiles, intracellular FLC concentrations, drug efflux, and sterol levels. by Pétra Vande Zande (17628246)

The association of p57^Kip2 with VDR is dependent on 1,25-(OH)₂VD₃. by Katsuhiko Takahashi (4163194)

Changes to distal lung structure of both α7 genotypes with and without CS exposure. by Lorise C. Gahring (271630)

“…In these representative sections the arrows point to AMs and in the α7^E260A:G arrow heads identify regions of increased cellularity that produce alveolar sacs of decreased size. …”

Timing of treatment affects early post-rebound viral levels. by Mykola Pinkevych (125551)

“…Black lines show the best fit of the nonlinear regression (see <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011660#sec012" target="_blank">methods</a> and Formula (<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011660#ppat.1011660.e002" target="_blank">2</a>)) that estimates the early decrease, inflection point, and later increase in viral levels. …”

Sample application of the ghosts of finite-time singularities in the deterministic system (1) for parameters <i>b</i> = 0.42 and <i>g</i> = −0.04. by Damian Smug (5040890)

Mutation of acetylated lysine residues results in mislocalization of NDPK-D. by Yuki Fujita (330873)

“…(C, D) SIRT1, but not catalytic-dead point mutant (H363Y) deacetylates NDPK-D in N1E-115 cells. …”

Determination of IC₅₀ and maximum induction of VPA using Vero cells. by Amanda Watson (4447267)

Digital elevation model (DEM) map of northern China. by Hanchao Jiang (4509973)